What Miklos and Moore does

Miklos and Moore is a physician-owned, fellowship-trained urogynecology and cosmetic vaginal surgery practice founded by Dr. John R. Miklos and Dr. Robert D. Moore. The practice specializes in minimally invasive pelvic reconstructive surgery and cosmetic vaginal procedures, including laparoscopic sacrocolpopexy, hysteropexy (uterine preservation), laparoscopic Davydov neovagina creation for MRKH patients, complete transvaginal mesh removal, vaginal rejuvenation, labiaplasty, and non-surgical options such as ThermiVa, Morpheus V, O-Shot, and G-Shot. Their differentiation rests on pioneering multiple procedures—including the first clinical study and first textbook chapter on vaginal rejuvenation—and on procedure volumes (1,000+ mesh removals, 1,500+ sacrocolpopexy procedures, 3,000+ vaginal rejuvenation surgeries, 5,000+ cosmetic procedures) that no comparable practice is reported to match, particularly for complex cases rejected by major academic centers.

The practice operates from four physical locations (Atlanta, Beverly Hills, Charleston, Dubai) supplemented by virtual consultations, serving patients from all 50 US states and 54 countries. Revenue is generated through professional services fees spanning insurance-reimbursed procedures (prolapse, incontinence, mesh removal via UMR, United Healthcare, Blue Cross Blue Shield) and self-pay cosmetic procedures priced on a non-disclosed basis, with patient financing available. The go-to-market relies on reputation-driven direct consultation, peer physician referrals from gynecologists, urologists, and primary urogynecologists, international medical tourism coordination, and a substantial PR footprint (Cosmopolitan, Self, Delta Sky, The Doctors TV, New Beauty, among others). Community partnerships with four MRKH foundations and a private patient Facebook group formalize demand-generation around the practice's rare-condition niche.

The business is a founder-owned private practice without venture capital, private equity involvement, or external institutional ownership; headcount is reported in the 11-50 range. Strategic emphasis is on continued accumulation of subspecialty expertise, geographic presence maintenance rather than rapid network expansion, and educational outreach (international society teaching, surgical video library, published papers) that reinforces referral flow and category leadership rather than top-of-funnel consumer advertising.

Name

Miklos and Moore

Legal name

Miklos and Moore

Website

https://miklosandmoore.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Miklos and Moore is a physician-owned urogynecology and cosmetic vaginal surgery practice specializing in minimally invasive pelvic reconstruction, mesh removal, vaginal rejuvenation, and MRKH neovagina creation, serving patients from 50 US states and 54 countries across four offices in Atlanta, Beverly Hills, Charleston, and Dubai.

Ownership category

akta.pro rank

Product category

Urogynecology and Cosmetic Vaginal Surgery

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Urogynecology & Pelvic Reconstructive Surgery (Female Pelvic Medicine) (HLAKAJAE)

akta.pro secondary industries

Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy) (HLAKAJAF), Female Pelvic Medicine & Reconstructive Surgery (Urogynecology) (HLAKAOAC)

Keywords

• Urogynecology services
• Cosmetic vaginal surgery
• Pelvic reconstructive surgery
• Mesh removal surgery
• Non-surgical vaginal rejuvenation

Headquarters

HQ city

Alpharetta

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Surgical Procedures: Revenue generated from surgical procedures including vaginal rejuvenation/vaginoplasty, labiaplasty, mesh removal, prolapse repair, and MRKH neovagina creation. Procedures are performed in hospital or surgical center settings.
2. Non-Surgical Treatments: Revenue from in-office non-surgical procedures including ThermiVa, Morpheus V vaginal rejuvenation, O-Shot, and G-Shot injections.
3. Insurance-Reimbursed Procedures: Many procedures are medically necessary and covered by insurance including UMR, United Healthcare, Blue Cross Blue Shield. The practice accepts insurance for prolapse repairs, incontinence procedures, and mesh removal. Cosmetic procedures such as vaginal rejuvenation are typically self-pay but the practice notes that patients with prolapse diagnoses may have insurance cover a portion.
4. Consultation Fees: Revenue from initial consultations, both in-person and virtual, as well as follow-up appointments and preoperative/postoperative care.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels10 records

Core offering

Miklos and Moore is a urogynecology and cosmetic vaginal surgery practice offering specialized surgical and non-surgical procedures for women. Core offerings include cosmetic vaginal surgery (vaginal rejuvenation, labiaplasty), pelvic floor reconstruction (mesh complication treatment, incontinence solutions, prolapse surgery), MRKH neovagina creation, and non-surgical treatments (ThermiVa, Morpheus V, O-Shot, G-Shot). The practice performs over 5,000 cosmetic surgical procedures and serves patients from all 50 US states and 54 countries.

Product overview

Miklos and Moore is a urogynecology and cosmetic vaginal surgery practice offering a comprehensive portfolio of surgical and non-surgical procedures. The practice operates as a single unified service model with multiple specialized procedures rather than a platform-plus-modules architecture. Core offerings include cosmetic vaginal surgery procedures (vaginal rejuvenation, labiaplasty, clitoral hood reduction, perineoplasty, hymenoplasty), pelvic floor reconstruction (mesh complication treatment, urinary incontinence solutions, prolapse surgery including hysteropexy and sacrocolpopexy), MRKH treatment (laparoscopic Davydov neovagina creation), and non-surgical treatments (ThermiVa, Morpheus V, O-Shot, G-Shot). Services are supported by virtual consultations, patient financing, and educational resources including surgical video libraries and published scientific papers. The practice has multiple locations in Atlanta, Beverly Hills, Charleston, Miami, and Dubai.

Differentiator

Problem solved

Functional benefit

Products and services

• Vaginal Rejuvenation – Surgical Tightening Surgical procedure to address vaginal laxity by tightening the vaginal muscles and tissues, performed for women with loss of sensation during intercourse, lack of friction, or decreased sexual satisfaction.
• Labiaplasty – Labia Minora Reduction Surgical reduction of the labia minora to reduce size or correct asymmetry, performed for women with labial hypertrophy or aesthetic concerns.
• Labiaplasty – Labia Majora Reduction Surgical reduction of the labia majora to address sagging skin outside the vagina, performed for women with labial hypertrophy or aesthetic concerns.
• Mesh Complications Treatment Treatment and removal of mesh complications from previous pelvic floor surgeries including TVT slings, TOT slings, and transvaginal mesh, using combined vaginal and laparoscopic approaches.
• Urinary Incontinence Solutions Treatment for urinary incontinence including TOT, TVT, mini sling, ALTIS-mini sling, Burch procedures, and vesico vaginal fistula repair.
• Hysteropexy – Uterine Preservation Laparoscopic uterine suspension surgery to preserve the uterus while treating uterine prolapse, achieving 98% surgical success rate.
• Sacrocolpopexy Surgical procedure to repair vaginal vault prolapse using mesh attached to the sacrum via laparoscopic approach.
• Cystocele/Paravaginal Repair Laparoscopic repair of bladder prolapse by re-attaching the vaginal ceiling to the pelvic floor muscles (obturator internus).
• MRKH – Laparoscopic Davydov Neovagina Creation of a neovagina for women born without a vaginal canal (MRKH syndrome) or vaginal lengthening for shortened vaginas using the laparoscopic Davydov technique.
• Vaginal Rejuvenation – ThermiVa In-office, non-surgical, pain-free procedure for vaginal laxity using ThermiVa radiofrequency technology.
• Vaginal Rejuvenation – Morpheus V Non-surgical vaginal rejuvenation treatment using Morpheus V radiofrequency technology.
• The O-Shot Platelet-rich plasma (PRP) injection for women's intimate wellness.
• G-Shot Hyaluronic acid injection to enhance the G-spot area.
• Virtual Consultation Remote consultation service allowing patients to discuss concerns and submit photos for evaluation, particularly for international and out-of-state patients.

Quantifiable outcome

• Over 1,000 pieces of mesh removed; 90% vaginal rejuvenation satisfaction rate; 97% labiaplasty satisfaction rate; 98%+ sacrocolpopexy cure rate; 95%+ hysteropexy success rate; 97%+ MRKH neovagina success rate
• +2 more outcomes

Named customers8 records

Segments7 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Twelve partnerships are on record, tiered moderate, core and minor.

• Beautful You MRKH FoundationmoderateOthersMRKH patient support organization. The practice partners with this foundation to provide resources and support connections for women diagnosed with MRKH syndrome. Danielle at miklosandmoore.com serves as the contact point for the private support group.
• Center for Young Women's HealthmoderateOthersPartner organization providing MRKH-related health information. Listed as a trusted resource on the practice's support page alongside other MRKH foundations.
• Living MRKH (UK)moderateOthersUK-based MRKH patient support organization. Listed as a resource partner to connect patients with support communities.
• Mid-Atlantic MRKH FoundationmoderateOthersRegional MRKH foundation providing support and resources. Listed as a referral resource on the practice's support page.
• Northside Hospital (Atlanta)coreOthersPrimary hospital partner for surgical procedures in Atlanta. The practice performs surgeries at Northside Hospital with staff providing postoperative care and support.
• UMR InsurancemoderateOthersInsurance provider accepted for rectocele repair, cystocele repair, and other medically necessary procedures. The practice works with UMR to verify coverage and maximize patient benefits.
• United HealthcaremoderateOthersMajor insurance provider accepted for eligible medical procedures. The practice works with United Healthcare to determine eligibility for prolapse and incontinence surgeries.
• Blue Cross Blue ShieldmoderateOthersMajor insurance provider accepted for medically necessary urogynecology and prolapse procedures. The practice verifies benefits and helps patients understand coverage.
• European Society of Aesthetic Gynecology (ESAG)moderateStrategic or Co-development PartnerInternational medical society that invites Drs. Miklos and Moore to teach and lecture on cosmetic vaginal surgery techniques throughout the world.
• International Society of Cosmetogynecology (ISCG)moderateStrategic or Co-development PartnerInternational medical society specializing in cosmetic gynecology. The practice is recognized as leaders and invited to teach by ISCG.
• American Association Gynecologic Laparoscopy (AAGL)moderateStrategic or Co-development PartnerLeading organization in gynecologic laparoscopy. Dr. Moore is a member and has provided educational content including suturing technique videos for AAGL.
• Association Latino American Pelvic Surgery (ALAPP)minorStrategic or Co-development PartnerLatin American pelvic surgery society that invites the practice to teach internationally on laparoscopic urogynecology techniques.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

Others

• InMode: Manufacturer of the Morpheus V and other radiofrequency platforms used by Miklos and Moore for non-surgical vaginal rejuvenation. A key enabling-technology supplier and an indirect ecosystem participant whose device adoption and brand directly affect the practice's non-surgical offering.
• ThermiGen (ThermiVa): Manufacturer of the ThermiVa radiofrequency system used by Miklos and Moore. A direct enabling-technology vendor; competitive dynamics and pricing with InMode shape the unit economics of the practice's non-surgical suite.

Direct peers

• Laser Vaginal Rejuvenation Institute (Dr. David Matlock): Pioneer of the 'Laser Vaginal Rejuvenation' branded category and a founding figure in cosmetic gynecology. Directly comparable subspecialty offering (vaginoplasty, labiaplasty, designer laser procedures) targeting the same self-pay cosmetic patient base.
• Dr. Red Alinsod (South Coast Urogynecology): Fellowship-trained urogynecologist and one of the early pioneers of cosmetic vaginal surgery in the US. Performs comparable procedures (labiaplasty, vaginoplasty, ThermiVa, mesh revision) and is a fellow member of the same international societies (ISCG, ESAG), making him a direct specialty peer to Miklos and Moore.
• Pelosi Medical Center (Dr. Mark Pelosi): Cosmetic gynecology practice known for vaginoplasty, labiaplasty, and clitoral unhooding. Overlaps directly with Miklos and Moore on cash-pay cosmetic procedures and the international cosmetogynecology teaching circuit (ISCG, ESAG).

Broad incumbents

• Mayo Clinic Urogynecology: Large academic urogynecology division delivering the full range of prolapse, incontinence, and reconstructive procedures. Comparable on medically necessary urogynecology but does not specialize in cash-pay cosmetic vaginal surgery.
• Cleveland Clinic Urogynecology & Pelvic Floor Disorders Center: Major academic urogynecology program performing prolapse, incontinence, mesh complication, and reconstructive procedures as part of a broader women's health portfolio. Represents the academic-institution counterpart that sometimes refers complex cases to Miklos and Moore.

Emerging players

• Viveve: Medical technology company marketing the Viveve System for non-surgical vaginal tissue revitalization. Represents an emerging device-based competitor in the non-surgical rejuvenation category where Miklos and Moore also compete with ThermiVa and Morpheus V.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/miklosandmoore
• YouTubeyoutube.com/miklosandmoore
• Facebookfacebook.com/drs.miklosandmoore
• Instagraminstagram.com/drs.miklosandmoore
• LinkedInlinkedin.com/company/miklos-moore-international-associates

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Miklos and Moore